LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Peptide containing doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

N-substituted derivatives of 1-desaminovasopressin

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

N-substituted glutamic acid derivatives with interleukin-1 .beta

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

N-substituted glutamic acid derivatives with interleukin-1.beta.

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

N-substituted-amido-amino acids

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

N-Substituted-amindo-amino acids

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

N-sulfonylarginine keto-amide compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

N-terminal D(-)-penicillamine peptides as aldehyde...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

N-terminal site selective inhibitors of human angiotensin...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

N-terminally chemically modified protein compositions and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

N-terminally modified GLP-1 receptor modulators

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

N-terminally truncated galectin-3 for use in treating cancer

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

N-terminally truncated hst-1 is a platelet-increasing factor

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

N-terminus modified analogs of LHRH

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

N-terminus modified analogs of LHRH

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

N-ureidoalkyl-piperidines as modulators of chemokine...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

N-[N.sup..alpha. -(1(S)-carboxy-3-cyclohexylpropyl)-L-lysyl]-N-c

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

N.sup..alpha. -desacetylthymosin.alpha..sub.1 and process

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

N.sup.2 -(Substituted)carboxymethyl-N.sup.6 -(substituted)-lysyl

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

N.sup.2 -dansyl-L-arginine derivatives, and the pharmaceutically